Browse

Initial findings show that the therapy reduced or eliminated disease signs in all recipients, sparking hopes that the treatment might be competitive with “ex vivo” medicines like Novartis’ Kymriah.

The Morning Rounds newsletter, written by Theresa Gaffney, raises a question about whether military environments are encouraging eating disorders. The piece is part of a daily health briefing that…